CLEW Nicotine Pouches Earns Esteemed Award at Vapecon South Africa 2024
In a remarkable showcase of innovation and quality, CLEW Nicotine Pouches has been awarded the title of Best Nicotine Pouch at the prestigious Vapecon South Africa 2024. This accolade, achieved at Africa's leading vaping event, underscores CLEW's dedication to providing high-quality smokeless nicotine alternatives that cater to a diverse audience seeking satisfying experiences without the need for traditional smoking.
Since its inception, CLEW has made considerable strides in establishing itself as a frontrunner in the alternative nicotine market, particularly with its innovative pouches that deliver nicotine without combustion. The company has effectively responded to the growing demand for smoke-free options, especially among consumers looking for alternatives that align with a healthier lifestyle.
The recognition at Vapecon is particularly significant as it marks CLEW’s second global award this year, following their win for Best Nicotine Pouch at the MENA Vape Awards held in June 2024. This achievement not only highlights the quality of their products but also reinforces the brand’s position as a leader within the smokeless nicotine sector.
A pivotal part of the event was the enlightening keynote speech delivered by CLEW’s CEO, Mr. Waqas Khan. In his address, he explored the latest trends and developments within the realm of alternative nicotine products, stressing the importance of harm reduction strategies and the necessity for regulations that support public health advancements. Mr. Khan shared his personal journey of developing innovative nicotine alternatives and emphasized the role of collaboration among regulators, policymakers, and industry stakeholders for fostering an environment conducive to harm reduction initiatives.
Mr. Khan expressed his gratitude for the award, stating, "We are thrilled to receive the Best Nicotine Pouch award at Vapecon South Africa. This recognition validates our commitment to innovative nicotine alternatives. Thank you to the jury and participants for their support. The show served as a fantastic platform to showcase our products and engage in meaningful discussions about harm reduction, which we believe will significantly aid our growth in the African markets."
CLEW Nicotine Pouches are produced in cGMP and HACCP-certified facilities, ensuring adherence to the highest safety and quality standards in manufacturing. The pouches are designed for convenient use, allowing users to enjoy sustained nicotine delivery paired with long-lasting flavors, including refreshing mint and classic tobacco options, all while providing a smooth mouthfeel.
With a range of nicotine strengths from 3mg to 20mg, CLEW expertly caters to a wide spectrum of consumer preferences, making it an attractive option for both newcomers and seasoned users alike.
Furthermore, the 2024 FDA acceptance of CLEW's Premarket Tobacco Product Application (PMTA) marks a significant milestone in the brand’s mission to provide discreet, smoke-free options to adult nicotine consumers. This regulatory approval underscores the company’s compliance with stringent safety and quality regulations, reinforcing trust among consumers and paving the way for further expansions into new markets.
As CLEW continues to cement its position as a leader in the nicotine alternatives space, the company looks to the future with a vision of creating a meaningful impact on public health through innovative product offerings. For additional details about their products and commitment to public health, interested readers can visit CLEW's official website.
Since its inception, CLEW has made considerable strides in establishing itself as a frontrunner in the alternative nicotine market, particularly with its innovative pouches that deliver nicotine without combustion. The company has effectively responded to the growing demand for smoke-free options, especially among consumers looking for alternatives that align with a healthier lifestyle.
The recognition at Vapecon is particularly significant as it marks CLEW’s second global award this year, following their win for Best Nicotine Pouch at the MENA Vape Awards held in June 2024. This achievement not only highlights the quality of their products but also reinforces the brand’s position as a leader within the smokeless nicotine sector.
A pivotal part of the event was the enlightening keynote speech delivered by CLEW’s CEO, Mr. Waqas Khan. In his address, he explored the latest trends and developments within the realm of alternative nicotine products, stressing the importance of harm reduction strategies and the necessity for regulations that support public health advancements. Mr. Khan shared his personal journey of developing innovative nicotine alternatives and emphasized the role of collaboration among regulators, policymakers, and industry stakeholders for fostering an environment conducive to harm reduction initiatives.
Mr. Khan expressed his gratitude for the award, stating, "We are thrilled to receive the Best Nicotine Pouch award at Vapecon South Africa. This recognition validates our commitment to innovative nicotine alternatives. Thank you to the jury and participants for their support. The show served as a fantastic platform to showcase our products and engage in meaningful discussions about harm reduction, which we believe will significantly aid our growth in the African markets."
CLEW Nicotine Pouches are produced in cGMP and HACCP-certified facilities, ensuring adherence to the highest safety and quality standards in manufacturing. The pouches are designed for convenient use, allowing users to enjoy sustained nicotine delivery paired with long-lasting flavors, including refreshing mint and classic tobacco options, all while providing a smooth mouthfeel.
With a range of nicotine strengths from 3mg to 20mg, CLEW expertly caters to a wide spectrum of consumer preferences, making it an attractive option for both newcomers and seasoned users alike.
Furthermore, the 2024 FDA acceptance of CLEW's Premarket Tobacco Product Application (PMTA) marks a significant milestone in the brand’s mission to provide discreet, smoke-free options to adult nicotine consumers. This regulatory approval underscores the company’s compliance with stringent safety and quality regulations, reinforcing trust among consumers and paving the way for further expansions into new markets.
As CLEW continues to cement its position as a leader in the nicotine alternatives space, the company looks to the future with a vision of creating a meaningful impact on public health through innovative product offerings. For additional details about their products and commitment to public health, interested readers can visit CLEW's official website.
Topics Consumer Products & Retail）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.